REGIONAL CANCER-CHEMOTHERAPY

被引：0
|
作者：
ENSMINGER, WD
GYVES, JW
机构：
来源：
CANCER TREATMENT REPORTS | 1984年 / 68卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：101 / 115
页数：15
相关论文
共 50 条
  • [21] CYCLOCREATINE IN CANCER-CHEMOTHERAPY
    TEICHER, BA
    MENON, K
    NORTHEY, D
    LIU, J
    KUFE, DW
    KADDURAHDAOUK, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 35 (05) : 411 - 416
  • [22] NEOCARZINOSTATIN IN CANCER-CHEMOTHERAPY
    MAEDA, H
    ANTICANCER RESEARCH, 1981, 1 (03) : 175 - 185
  • [23] COMPLIANCE AND CANCER-CHEMOTHERAPY
    SMEDLEY, H
    BRATHERTON, D
    SIKORA, K
    BRITISH MEDICAL JOURNAL, 1983, 287 (6398): : 1067 - 1068
  • [24] CANCER-CHEMOTHERAPY IN THE ELDERLY
    BALDUCCI, L
    PHILLIPS, DM
    WALLACE, C
    HARDY, C
    AMERICAN FAMILY PHYSICIAN, 1987, 35 (03) : 133 - 143
  • [25] ANTIEMETICS AND CANCER-CHEMOTHERAPY
    LEONARD, RCF
    SOUKOP, M
    BRITISH JOURNAL OF CANCER, 1990, 61 (03) : 349 - 350
  • [26] CHEMOPROTECTANTS FOR CANCER-CHEMOTHERAPY
    DORR, RT
    SEMINARS IN ONCOLOGY, 1991, 18 (01) : 48 - 58
  • [27] PRODRUGS IN CANCER-CHEMOTHERAPY
    CONNORS, TA
    XENOBIOTICA, 1986, 16 (10-11) : 975 - 988
  • [28] APOPTOSIS AND CANCER-CHEMOTHERAPY
    HICKMAN, JA
    POTTEN, CS
    MERRITT, AJ
    FISHER, TC
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1994, 345 (1313) : 319 - 325
  • [29] PHARMACOKINETICS AND CANCER-CHEMOTHERAPY
    WORKMAN, P
    GRAHAM, MA
    CANCER SURVEYS, 1993, 17 : R7 - R8
  • [30] IMPROVED CANCER-CHEMOTHERAPY
    LOKICH, JJ
    POSTGRADUATE MEDICINE, 1990, 87 (02) : 239 - &
12345